Search Results

Filter
  • 1-10 of  650,229 results for ""HIV-1""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

  • Authors : Khamaikawin W; Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, 10520, Thailand.; Saisawang C

Subjects: Receptors, CCR5*/Receptors, CCR5*/Receptors, CCR5*/genetics ; Receptors, CCR5*/Receptors, CCR5*/Receptors, CCR5*/metabolism ; Gene Editing*/Gene Editing*/Gene Editing*/methods

  • Source: Scientific reports [Sci Rep] 2024 May 13; Vol. 14 (1), pp. 10852. Date of Electronic Publication: 2024 May 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola.

  • Authors : Sebastião CS; Centro de Investigação em Saúde de Angola (CISA), Caxito, Angola. .; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola. .

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/drug effects ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics

  • Source: Scientific reports [Sci Rep] 2024 Jul 10; Vol. 14 (1), pp. 15893. Date of Electronic Publication: 2024 Jul 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The origin and spread of HIV-1 CRF59_01B epidemic in China: A molecular network and phylogeographic analysis.

  • Authors : Yan H; Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China.; Wu H

Subjects: Phylogeography* ; HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/classification

  • Source: Journal of medical virology [J Med Virol] 2024 Jul; Vol. 96 (7), pp. e29799.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde.

  • Authors : Gonçalves P; Instituto de Investigação do Medicamento (iMed.Ulisboa), Faculdade de Farmácia de Lisboa, Lisbon, Portugal.; Barreto J

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/drug effects ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: AIDS (London, England) [AIDS] 2024 Jul 01; Vol. 38 (8), pp. 1101-1110. Date of Electronic Publication: 2024 Feb 12.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Rapid tests should be used with caution for HIV-1 primary infection screening.

  • Authors : Guiraud V; Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France.; Beaulieu Q

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/diagnosis ; Sensitivity and Specificity* ; HIV-1*/HIV-1*/HIV-1*/immunology

  • Source: Medical microbiology and immunology [Med Microbiol Immunol] 2024 Jun 22; Vol. 213 (1), pp. 10. Date of Electronic Publication: 2024 Jun 22.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0314524 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1831

Record details

×
Academic Journal

Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV-1 neutralizing antibodies.

  • Authors : Chen R; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Fu Y

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Vaccinia virus*/Vaccinia virus*/Vaccinia virus*/immunology

  • Source: Journal of medical virology [J Med Virol] 2024 Jun; Vol. 96 (6), pp. e29749.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/immunology

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 20; Vol. 24 (1), pp. 712. Date of Electronic Publication: 2024 Jul 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection.

  • Authors : Kumar S; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology (MIET), NH-58, Delhi-Roorkee Highway, Meerut, 250005, Uttar Pradesh, India.; Taumar D

Subjects: Atazanavir Sulfate*/Atazanavir Sulfate*/Atazanavir Sulfate*/pharmacokinetics ; Atazanavir Sulfate*/Atazanavir Sulfate*/Atazanavir Sulfate*/administration & dosage ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: Drug delivery and translational research [Drug Deliv Transl Res] 2024 Jul; Vol. 14 (7), pp. 1888-1908. Date of Electronic Publication: 2023 Dec 31.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study.

  • Authors : Dinesha TR; Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.; Boobalan J

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology

  • Source: HIV medicine [HIV Med] 2024 Jul; Vol. 25 (7), pp. 852-861. Date of Electronic Publication: 2024 Apr 25.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

×
Academic Journal

The prevalence of HIV resistance mutations and their influence on the shedding of HIV-1 into peritoneal dialysis effluent.

  • Authors : Mooko T; Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa.; Next Generation Sequencing Unit and Division of Virology, University of the Free State, Bloemfontein, South Africa.

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/drug effects ; HIV Infections*/HIV Infections*/HIV Infections*/virology

  • Source: Journal of medical virology [J Med Virol] 2024 Jun; Vol. 96 (6), pp. e29734.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
  • 1-10 of  650,229 results for ""HIV-1""